P4-147: RECOMBINANT ANTIBODIES AS NOVEL THERAPEUTICS FOR ALZHEIMER'S DISEASE

نویسندگان

چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Genetically recombinant antibodies: new therapeutics against candidiasis.

Historically, the therapy of serious fungal infection has been dominated by monotherapy with the polyene antibiotic amphotericin B. Clinical failures, side effects, the lack of alternatives and the toxicity of this drug have heightened the need to produce alternative therapies, which have included fluconazole, voriconazole and caspofungin. The observation that recovery from disseminated candidi...

متن کامل

Cancer as a metabolic disease: implications for novel therapeutics

Emerging evidence indicates that cancer is primarily a metabolic disease involving disturbances in energy production through respiration and fermentation. The genomic instability observed in tumor cells and all other recognized hallmarks of cancer are considered downstream epiphenomena of the initial disturbance of cellular energy metabolism. The disturbances in tumor cell energy metabolism can...

متن کامل

A systematic review of gold nanoparticles as novel cancer therapeutics

Objective(s):The current systematic study has reviewed the therapeutic potential of gold nanoparticles as nano radiosensitizers for cancer radiation therapy.   Materials and Methods: This study was done to review nano radiosensitizers. PubMed, Ovid Medline, Science Direct, SCOPUS, ISI web of knowledge, Springer databases were searched from 2000 to September 2013 to identify appropriate studies....

متن کامل

Recombinant Antibodies as Standards for Immunodiagnostic Assays

performance of immunodiagnostic assays and can vary from lab to lab according to factors such as assay reagents used, variation in the level of automation, operator experience and sample throughput. The quality and stability of assay components are critical to success. An important choice during assay development is the source of control and/or calibrator material and its standardization. Lack ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Alzheimer's & Dementia

سال: 2019

ISSN: 1552-5260

DOI: 10.1016/j.jalz.2019.06.3808